MediLumine is committed to providing high quality instruments, reagents and accessories to support preclinical imaging programs in the life sciences. MediLumine’s PRISM™ series of in vivo imaging systems are designed for preclinical monitoring of physiological changes in living systems for therapeutic discovery research in universities and pharmaceutical companies. MediLumine’s Fenestra® and Mvivo™ contrast agents for micro-CT Imaging provide image enhancement for various applications allowing scientists to monitor progression of functional liver diseases, quantify tumor burdens, track cells in vivo and perform preclinical angiography.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 5795 Av De Gaspé, Suite #228,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://medilumine.com
- Keywords
- Now Available through MediLumine 🚨.
- HQ
- Montreal, QC
Medilumine Questions
Medilumine's website is http://medilumine.com
Medilumine's LinkedIn profile is https://ca.linkedin.com/company/medilumine
Medilumine has
5 employees.
View email and phone details for 5
employees at Medilumine.
Medilumine's industry is
Biotechnology Research
Medilumine's top competitors are
Inspire Biotherapeutics Inc,
Vetiq,
Ingenuyx,
Iqvia,
Gremse-It,
Ri-Muhc | Research Institute Of The Muhc | #rimuhc,
Biodesign Synergy,
Laurent Pharmaceuticals,
Phantech, Llc,
Cordex Biologics.
Medilumine's categories are Biotechnology Research
Medilumine's founding year is 2013
